Cargando…
Efficacy and safety of “Jollab Monzej” as a traditional persian compound medicine for the treatment of multiple sclerosis-related fatigue: A randomized placebo-controlled trial
BACKGROUND: The purpose of this study was to investigate the efficacy and safety of Jollab monzej (JMZ), a Traditional Persian compound medicine, on multiple sclerosis-related fatigue (MSRF). METHODS: We did a double-blind randomized controlled phase3 clinical trial on the JMZ syrup in fifty-six rel...
Autores principales: | Yousefnia Babaki, Fatemeh, Khodadoost, Mahmood, Rezaeizadeh, Hossein, Naser Moghadasi, Abdorreza, Fahimi, Shirin, Hosseini, Hamed, Movahhed, Mina, Gharagozli, Kurosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201133/ https://www.ncbi.nlm.nih.gov/pubmed/37223302 http://dx.doi.org/10.22088/cjim.14.2.257 |
Ejemplares similares
-
Jollab: A Safe Remedy for Functional Dyspepsia in Persian Medicine
por: Pasalar, Mehdi, et al.
Publicado: (2021) -
Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis
por: Jafari, Zahra, et al.
Publicado: (2018) -
Psychometric properties of the Persian version of emotions and attitudes towards MRI” (MRI-EMA)
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2023) -
Fatigue Due to Multiple Sclerosis: A Comparison Between Persian Medicine and Conventional Medicine
por: Rezaeizadeh, Hossein, et al.
Publicado: (2019) -
Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis
por: Azadvari, Mohaddeseh, et al.
Publicado: (2020)